Literature DB >> 8780109

Deep brain stimulation for essential tremor.

J P Hubble1, K L Busenbark, S Wilkinson, R D Penn, K Lyons, W C Koller.   

Abstract

We examined the effects and safety of deep brain stimulation (DBS) as a treatment for essential tremor (ET). Ten ET patients with disabling medication-refractory tremor underwent stereotactic implantation of a DBS lead in the left Vim thalamic nucleus and completed a 6-month follow-up. The Clinical Tremor Rating Scale and disability assessments were performed at baseline, 1-, 3-, and 6-month follow-up. There were significant improvements in dressing, drinking, eating, bathing, and handwriting as reported by the subjects. Tremor severity, writing, pouring, and spiral and line drawing were significantly improved as rated by the examiner. Improvements persisted through the 6-month follow-up period. Although global disability significantly lessened in the group as a whole, one subject with hand-finger tremor accentuated by writing had no change in disability status. In this 6-month open-label study, DBS was effective and safe in reducing tremor and functional disability in ET.

Entities:  

Mesh:

Year:  1996        PMID: 8780109     DOI: 10.1212/wnl.46.4.1150

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  32 in total

1.  Neuropsychological and quality of life outcomes 12 months after unilateral thalamic stimulation for essential tremor.

Authors:  J A Fields; A I Tröster; S P Woods; C I Higginson; S B Wilkinson; K E Lyons; W C Koller; R Pahwa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-03       Impact factor: 10.154

2.  A Wearable System for Attenuating Essential Tremor Based on Peripheral Nerve Stimulation.

Authors:  Jeonghee Kim; Thomas Wichmann; Omer T Inan; Stephen P Deweerth
Journal:  IEEE J Transl Eng Health Med       Date:  2020-04-06       Impact factor: 3.316

3.  Essential Tremor.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

4.  Multicentre European study of thalamic stimulation in essential tremor: a six year follow up.

Authors:  O Sydow; S Thobois; F Alesch; J D Speelman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154

5.  Body weight gain in patients with bilateral deep brain stimulation for dystonia.

Authors:  Marc E Wolf; Hans-Holger Capelle; Götz Lütjens; Anne D Ebert; Michael G Hennerici; Joachim K Krauss; Christian Blahak
Journal:  J Neural Transm (Vienna)       Date:  2015-08-22       Impact factor: 3.575

6.  Wireless Instantaneous Neurotransmitter Concentration System-based amperometric detection of dopamine, adenosine, and glutamate for intraoperative neurochemical monitoring.

Authors:  Filippo Agnesi; Susannah J Tye; Jonathan M Bledsoe; Christoph J Griessenauer; Christopher J Kimble; Gary C Sieck; Kevin E Bennet; Paul A Garris; Charles D Blaha; Kendall H Lee
Journal:  J Neurosurg       Date:  2009-10       Impact factor: 5.115

Review 7.  Pediatric indications for deep brain stimulation.

Authors:  Matthew F DiFrancesco; Casey H Halpern; Howard H Hurtig; Gordon H Baltuch; Gregory G Heuer
Journal:  Childs Nerv Syst       Date:  2012-07-25       Impact factor: 1.475

Review 8.  Deep brain stimulation: are astrocytes a key driver behind the scene?

Authors:  Albert J Fenoy; Laurent Goetz; Stéphan Chabardès; Ying Xia
Journal:  CNS Neurosci Ther       Date:  2014-01-24       Impact factor: 5.243

Review 9.  Benefits and risks of pharmacological treatments for essential tremor.

Authors:  Kelly E Lyons; Rajesh Pahwa; Cynthia L Comella; Mahmood S Eisa; Rodger J Elble; Stanley Fahn; Joseph Jankovic; Jorge L Juncos; William C Koller; William G Ondo; Kapil D Sethi; Matthew B Stern; Caroline M Tanner; Ron Tintner; Ray L Watts
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 10.  The treatment of movement disorders by deep brain stimulation.

Authors:  Hong Yu; Joseph S Neimat
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.